<div class="container">

<table style="width: 100%;"><tr>
<td>fourD</td>
<td style="text-align: right;">R Documentation</td>
</tr></table>
<h2>
Placebo data from the 4D study
</h2>

<h3>Description</h3>

<p>Data from the placebo group of the 4D study. This study aimed at
comparing atorvastatin to placebo for patients with type 2 diabetes
and receiving hemodialysis in terms of cariovascular events. The
primary endpoint was a composite of
death from cardiac causes, stroke and non-fatal myocardial infarction.
Competing event was death from other causes.
</p>


<h3>Usage</h3>

<pre><code class="language-R">data(fourD)</code></pre>


<h3>Format</h3>

<p>A data frame with 636 observations on the following 7 variables.
</p>

<dl>
<dt><code>id</code></dt>
<dd>
<p>Patients' id number</p>
</dd>
<dt><code>sex</code></dt>
<dd>
<p>Patients' gender</p>
</dd>
<dt><code>age</code></dt>
<dd>
<p>Patients' age</p>
</dd>
<dt><code>medication</code></dt>
<dd>
<p>Character vector indicating treatment
affiliation. Here only equal to <code>"Placebo"</code></p>
</dd>
<dt><code>status</code></dt>
<dd>
<p>Status at the end of the follow-up. 1 for the
event of interest, 2 for death from other causes and 0 for
censored observations</p>
</dd>
<dt><code>time</code></dt>
<dd>
<p>Survival time</p>
</dd>
<dt><code>treated</code></dt>
<dd>
<p>Numeric vector indicated whether patients are
treated or not. Here always equal to zero</p>
</dd>
</dl>
<h3>Source</h3>

<p>Wanner, C., Krane, V., Maerz, W., Olschewski, M., Mann, J., Ruf, G.,
Ritz, E (2005). Atorvastatin in patients with type 2 diabetes mellitus
undergoing hemodialysis. New England Journal of Medicine, 353(3),
238â€“248.
</p>


<h3>References</h3>

<p>Allignol, A., Schumacher, M., Wanner, C., Dreschler, C. and
Beyersmann, J. (2010). Understanding competing risks: a simulation
point of view. Research report.
</p>


<h3>Examples</h3>

<pre><code class="language-R">data(fourD)
</code></pre>


</div>